He Jia-Hui, Shang De-Wei, Wang Zhan-Zhang, Li Xiao-Fang, Wen Yu-Guan
The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China.
Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, Guangdong Province, China.
Health Policy Open. 2022 Jan 13;3:100067. doi: 10.1016/j.hpopen.2022.100067. eCollection 2022 Dec.
In recent years, there has been a significant worldwide increase in the use of generic drugs. China has committed to a consistency evaluation of generic drugs, with the aim to improve the rate of substitution. However, there is little research on physicians' perceptions of generic drugs in China.
The study aimed to explore the perceptions of physicians in China toward generic drugs.
Perceptions of Chinese physicians towards generic drugs were evaluated by a cross-sectional study from June to July 2020. The online survey tool Sojump was adopted to distribute the questionnaires using convenience sampling. A total of 598 questionnaires were analyzed.
Perceptions of Chinese physicians towards generic drugs are generally positive. However, not all physicians appear to have sufficient knowledge about generic drugs and some of them expressed negative perceptions of generic drugs, such as perceiving generic drugs as less effective and more likely to cause side effects compared to brand-name drugs. There were significant differences in physicians' opinions about generic drugs according to age group, years in practice, educational background, clinical specialty and residential area.
It is imperative to provide physicians with more extensive education about the consistency evaluation of generic drugs to meet the policy goal of reducing overall national medical healthcare costs.
近年来,全球范围内仿制药的使用显著增加。中国致力于开展仿制药一致性评价,以提高替换率。然而,在中国,关于医生对仿制药看法的研究较少。
本研究旨在探讨中国医生对仿制药的看法。
通过2020年6月至7月的横断面研究评估中国医生对仿制药的看法。采用在线调查工具“问卷星”,通过便利抽样方式发放问卷。共分析了598份问卷。
中国医生对仿制药的看法总体上是积极的。然而,并非所有医生似乎都对仿制药有足够的了解,其中一些医生对仿制药表达了负面看法,例如认为仿制药与品牌药相比效果较差且更易引起副作用。医生对仿制药的看法在年龄组、执业年限、教育背景、临床专业和居住地区方面存在显著差异。
为实现降低国家总体医疗保健成本的政策目标,必须为医生提供更广泛的关于仿制药一致性评价的教育。